The 2 analysts offering 12-month price forecasts for Organogenesis Holdings Inc have a median target of 3.75, with a high estimate of 4.00 and a low estimate of 3.50. The median estimate represents a +37.36% increase from the last price of 2.73.
The current consensus among 2 polled investment analysts is to Buy stock in Organogenesis Holdings Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.04
Reporting Date Mar 12
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.